Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Price:
74.14 CNY
-0.88%
Market Closed
Updated:
May 18, 2024
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to FCFF
48.5
Current
61.7
Median
19.7
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
EV/FCFF
=48.5
Enterprise Value
/
54.8B
FCFF
1.1B
All Countries
| Market Cap | EV/FCFF | ||||
|---|---|---|---|---|---|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.3B CNY | 48.5 | |
| CH |
|
Alcon AG
SIX:ALC
|
39.5B CHF | 88.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.6T JPY | 36.5 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
191.1B DKK | 48.3 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 32.1 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
19.3B USD | 161.6 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 529.1 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.7T KRW | -72.8 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 26.3 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 26.2 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.1B USD | -71.7 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A
You don't have any saved screeners yet
